The VISION-MD Study

  • Research type

    Research Study

  • Full title

    The measurement of VItal SIgns by Lifelight® software in comparisON to the standard of care – Multi-site Development (The VISION-MD study)

  • IRAS ID

    289242

  • Contact name

    Anoop Chauhan

  • Contact email

    anoop.chauhan@porthosp.nhs.uk

  • Sponsor organisation

    Xim Limited

  • Duration of Study in the UK

    0 years, 11 months, 30 days

  • Research summary

    Lifelight® is a computer program (“app”) which can be used on standard smart devices that contain a camera. The app uses data from looking at a person’s face to calculate four vital signs: blood pressure, heart rate, blood oxygen levels and breathing rate. The app is still under development, meaning that it is still “learning” the best match between the information it collects from the face and the values of vital signs measured using standard equipment. The app needs more information from people with abnormal blood pressure and blood oxygen levels to become accurate. In order to capture the full range of observations, the app will need to be trialled with some of the most critically ill patients - some of these will not have capacity to consent to participation in the study. It also needs to see more data from people with different skin tones so we can be sure it is accurate for all patients.

    This study will recruit people who are attending either one of two hospitals or a GP clinic, either as an inpatient, an outpatient, a friend/relative of a patient, or a member of staff. The exact number will depend on how quickly the app “learns” and how many of the vital signs are outside of the normal range. We will take the participant’s vital signs using standard clinical equipment while we record a video of their face. We will use most of these measurements and video to teach the app how to become more accurate at measuring vital signs. We will keep the remaining data separate and use it to test how accurate the app is. All of the data will be kept securely and participants will not be able to be identified.

    We will also collect feedback from participants and healthcare staff on their experiences using the app through an interview or questionnaire. We will record information that allows us to assess whether there are any savings to the healthcare economy through using this technology.

  • REC name

    South Central - Berkshire Research Ethics Committee

  • REC reference

    20/SC/0432

  • Date of REC Opinion

    24 Nov 2020

  • REC opinion

    Favourable Opinion